U.S. Manufacture. To the extent required, Licensee agrees to abide by the Preference for United States Industry as set forth in 37 CFR 401.14 (I).
Appears in 10 contracts
Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Synthorx, Inc.), License Agreement (Synthorx, Inc.)
U.S. Manufacture. To the extent required, Licensee agrees to abide by the Preference for United States Industry as set forth in 37 CFR 401.14 (I), which includes Licensee’s agreement that any Licensed Product or Licensed Process sold in the United States shall be manufactured substantially in the United States.
Appears in 5 contracts
Samples: License Agreement (Fate Therapeutics Inc), License Agreement (Fate Therapeutics Inc), License Agreement (Fate Therapeutics Inc)
U.S. Manufacture. To the extent requiredrequired by applicable law, Licensee agrees to abide by the Preference for United States Industry as set forth in 37 CFR 401.14 (I).
Appears in 3 contracts
Samples: License Agreement (Ambrx Biopharma Inc.), License Agreement (Ambrx Biopharma Inc.), License Agreement (Ambrx Inc)
U.S. Manufacture. To the extent requiredapplicable, Licensee agrees to abide by the Preference for United States Industry as set forth in 37 CFR 401.14 (I).
Appears in 2 contracts
Samples: Research Funding and Option Agreement (aTYR PHARMA INC), Research Funding and Option Agreement (aTYR PHARMA INC)
U.S. Manufacture. To the extent required, Licensee agrees to abide by the Preference for United States Industry as set forth in 37 CFR 401.14 (I)) and exemptions and exceptions thereof, each as may be amended or restated from time to time.
Appears in 1 contract
